Shijiazhuang Yiling Pharmaceutical Hits Day High with 6% Surge

Shijiazhuang Yiling Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 6.0% on June 29, 2026. The stock reached an intraday high of CNY 15.55, reflecting a strong day of trading for the large-cap company in the Pharmaceuticals & Biotechnology sector. In comparison to the broader market, Shijiazhuang Yiling's one-day performance notably outpaced the China Shanghai Composite, which rose by just 1.16%. Over the past week, the stock has shown a positive trend, increasing by 3.26%, while the Shanghai Composite declined by 2.14%. Despite a challenging year-to-date performance of -8.96%, the company has reported impressive financial metrics, including a 42.92% growth in net profit as of March 26, and a record operating cash flow of CNY 2,055.74 million. Additionally, the company has maintained a return on equity of 11.96% and a price-to-earnings ratio of 15.00, indicating a solid financial position within its industry.